Table 1. Interventional cytopathology: analysis of technical advantages in the context of the COVID-19 pandemic.
| Patient acceptance of the procedure | Yes |
| Coagulation tests | Not essential |
| Need for surgical risk | No |
| Need for surgeon | No |
| Special materials and instruments | No |
| Recovery room | No |
| Number of staff needed | 1 to 2 |
| PPE | Complete |
| Speed of procedure | Minutes |
| Soft tissue trauma | Minimal |
| Pain | Minimal |
| Need for analgesics | Usually not needed |
| Risk of complications | Minimal |
| Sample processing time | Minutes |
| Waiting time for result | Less than 24 hours |
| Evaluation of sample quality | May be immediate |
| Repetition of procedure | Immediate |
| Costs | Low |
| Risk of infection for operators during the process | During the expulsion and extension of the sample |